Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-093481
Filing Date
2024-11-01
Accepted
2024-11-01 16:00:42
Documents
2
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0219660-6k_universe.htm 6-K 9527
2 PRESS RELEASE - UNIVERSE PHARMACEUTICALS INC RECEIVES NASDAQ NOTIFICATION REGARD ea021966001ex99-1_universe.htm EX-99.1 7376
  Complete submission text file 0001213900-24-093481.txt   18047
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

EIN.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40231 | Film No.: 241418981
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)